Koyfin Home > Directory > Health Care > Intersect Ent Inc

Intersect Ent Inc Price Chart XENT

Historical daily share price chart and data for Intersect Ent Inc since 2014 adjusted for splits and dividends. The latest closing price for Intersect Ent Inc as of October 20, 2020 is $15.805.
  • In 2020 the stock opened at $25.26 and closed at $15.81 for a loss of -60% YTD.
  • In 2019 the stock opened at $27.77 and closed at $24.90 for a loss of -12%.
  • In 2018 the stock opened at $33.95 and closed at $28.18 for a loss of -20%.
  • In 2017 the stock opened at $12.20 and closed at $32.40 for a gain of 62%.
View Chart On Koyfin

Intersect Ent Inc Summary

Stock Symbol: XENT

Intersect Ent Inc Company Info

Intersect ENT, Inc., a drug delivery company, researches and develops products for the treatment of patients with ear, nose, and throat conditions in the United States. The company offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
82.21 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of XENT Prices